HLB Pharmaceutical Co., Ltd. (KOSDAQ:047920)
South Korea · Delayed Price · Currency is KRW 13,550
-100 (-0.73%)
Aug 29, 2025, 12:38 PM KST
HLB Pharmaceutical Market Cap
HLB Pharmaceutical has a market cap or net worth of 191.68 billion as of August 28, 2025. Its market cap has decreased by -43.83% in one year.
Market Cap
191.68B
Enterprise Value
179.33B
Revenue
36.10B
Ranking
n/a
PE Ratio
405.53
Stock Price
13,550.00
Market Cap Chart
Since December 21, 2015, HLB Pharmaceutical's market cap has increased from 84.28B to 191.68B, an increase of 127.43%. That is a compound annual growth rate of 8.85%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Aug 28, 2025 | 191.68B | -43.36% |
| Dec 30, 2024 | 338.42B | 58.45% |
| Dec 28, 2023 | 213.58B | 43.49% |
| Dec 29, 2022 | 148.85B | -21.48% |
| Dec 30, 2021 | 189.57B | -21.05% |
| Dec 30, 2020 | 240.12B | 219.34% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
| Dec 21, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 72.60T |
| Celltrion | 37.63T |
| ALTEOGEN | 22.61T |
| Yuhan | 8,694.51B |
| SK Biopharmaceuticals | 7,893.98B |
| Peptron | 7,466.80B |
| PharmaResearch | 7,314.31B |
| LigaChem Biosciences | 5,419.69B |